Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study (Q49154119)
Jump to navigation
Jump to search
scientific article published on 26 June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study |
scientific article published on 26 June 2009 |
Statements
1 reference
Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study (English)
1 reference
E Daudén
1 reference
J-P Ortonne
1 reference
K Kragballe
1 reference
C T Molta
1 reference
D Robertson
1 reference
R Pedersen
1 reference
J Estojak
1 reference
R Boggs
1 reference
26 June 2009
1 reference
23
1 reference
12
1 reference
1374-1382
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference